SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-14-151305
Filing Date
2014-04-22
Accepted
2014-04-21 20:44:37
Documents
6
Effectiveness Date
2014-04-22

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE ADDITIONAL MATERIALS d711497ddefa14a.htm DEFA14A 53058
2 GRAPHIC g711497img2.jpg GRAPHIC 2273
3 GRAPHIC g711497notice_pg001a.jpg GRAPHIC 6629
4 GRAPHIC g711497notice_pg002a.jpg GRAPHIC 2016
5 GRAPHIC g711497notice_pg002b.jpg GRAPHIC 2097
6 GRAPHIC g711497notice_pg003.jpg GRAPHIC 2067
  Complete submission text file 0001193125-14-151305.txt   75595
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 000-26727 | Film No.: 14775080
SIC: 2834 Pharmaceutical Preparations